US Stock MarketDetailed Quotes

ImmuCell (ICCC)

Watchlist
  • 6.380
  • -0.220-3.33%
Close Apr 8 16:00 ET
  • 6.900
  • +0.520+8.15%
Post 18:54 ET
57.72MMarket Cap-53.17P/E (TTM)

ImmuCell (ICCC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
4.34%27.64M
-1.61%7.63M
-8.41%5.51M
17.76%6.44M
11.16%8.07M
51.64%26.49M
52.10%7.75M
11.40%6.01M
54.92%5.47M
110.58%7.26M
Operating revenue
4.34%27.64M
-1.61%7.63M
-8.41%5.51M
17.76%6.44M
11.16%8.07M
51.64%26.49M
52.10%7.75M
11.40%6.01M
54.92%5.47M
110.58%7.26M
Cost of revenue
-12.68%16.2M
-4.14%4.72M
-29.02%3.14M
-14.51%3.63M
-5.02%4.71M
36.39%18.55M
28.17%4.92M
7.23%4.43M
70.46%4.24M
57.74%4.96M
Gross profit
44.13%11.45M
2.77%2.91M
49.23%2.36M
129.01%2.82M
46.12%3.35M
105.23%7.94M
125.14%2.83M
25.00%1.58M
17.88%1.23M
663.15%2.3M
Operating expense
2.24%9.8M
34.29%2.97M
8.55%2.34M
-14.09%2.25M
-13.83%2.24M
-0.38%9.58M
-2.25%2.21M
-11.93%2.16M
11.44%2.62M
1.51%2.6M
Selling and administrative expenses
18.85%6.75M
58.84%2.21M
20.14%1.65M
-10.72%1.42M
11.00%1.48M
8.81%5.68M
16.41%1.39M
2.99%1.37M
27.04%1.59M
-7.85%1.33M
-Selling and marketing expense
2.52%3.55M
29.32%1.08M
8.91%919.29K
-29.33%696.09K
6.96%856.66K
12.24%3.47M
24.52%836.15K
3.25%844.05K
36.84%984.96K
-8.93%800.92K
-General and administrative expense
44.40%3.2M
103.34%1.13M
38.08%729.42K
19.74%720.42K
17.09%622.84K
3.85%2.22M
6.01%554.71K
2.59%528.27K
13.72%601.63K
-6.19%531.94K
Research and development costs
-21.97%3.04M
-7.39%758.86K
-11.68%694.31K
-19.28%831.86K
-40.05%756.85K
-11.29%3.9M
-23.17%819.39K
-29.71%786.14K
-6.28%1.03M
13.71%1.26M
Operating profit
200.56%1.65M
-109.33%-57.96K
103.49%20.08K
141.08%569.56K
472.48%1.12M
71.47%-1.64M
161.92%621.4K
51.45%-574.89K
-6.29%-1.39M
86.70%-300.05K
Net non-operating interest income expense
31.84%-334.68K
25.49%-74.49K
25.83%-93.05K
40.61%-76.68K
33.72%-90.46K
-29.55%-491.02K
25.94%-99.97K
-3.75%-125.46K
-75.03%-129.12K
-176.53%-136.48K
Non-operating interest income
104.25%158.71K
-12.61%31.66K
121.93%41.47K
262.73%48.11K
293.29%37.47K
-19.54%77.7K
107.77%36.23K
-21.15%18.69K
-10.41%13.26K
-76.55%9.53K
Non-operating interest expense
-16.54%439.04K
-17.87%102.99K
-21.30%104.94K
-12.35%124.8K
-13.73%117.12K
16.13%526.06K
-11.90%125.39K
-1.91%133.34K
60.75%142.39K
50.87%135.76K
Total other finance cost
27.38%54.35K
-70.79%3.16K
173.74%29.58K
----
5.46%10.81K
88.63%42.67K
7.06%10.81K
24.38%10.81K
----
--10.25K
Other net income (expense)
-15,123.75%-2.34M
-325,247.00%-2.71M
-62.32K
174.91%10.9K
421.72K
-104.31%-15.39K
-834
-19,005.19%-14.56K
Special income (charges)
-15,148.28%-2.35M
-325,247.00%-2.71M
---62.32K
148.97%7.13K
--421.72K
-104.31%-15.39K
---834
--0
-19,005.19%-14.56K
--0
-Less:Impairment of capital assets
--2.67M
----
----
----
----
----
----
----
----
----
-Less:Other special charges
---426.59K
--0
----
----
---426.59K
----
----
----
----
----
-Gain on sale of property,plant,equipment
-590.99%-106.35K
-5,450.84%-46.29K
---62.32K
148.97%7.13K
---4.87K
-90.04%-15.39K
---834
--0
-19,005.19%-14.56K
--0
Other non- operating income (expenses)
--3.78K
--0
----
--3.78K
----
----
----
----
----
----
Income before tax
52.09%-1.03M
-646.65%-2.85M
80.68%-135.29K
132.92%503.78K
431.91%1.45M
62.80%-2.15M
145.73%520.59K
25.48%-700.35K
-11.04%-1.53M
81.13%-436.53K
Income tax
15.06%11.57K
-45.23%3.31K
232.54%4.46K
42.09%1.9K
42.09%1.9K
117.33%10.06K
347.77%6.04K
485.15%1.34K
-12.13%1.34K
-12.13%1.34K
Net income
51.78%-1.04M
-653.71%-2.85M
80.08%-139.75K
132.77%501.88K
430.46%1.45M
62.65%-2.16M
145.14%514.56K
25.35%-701.69K
-11.01%-1.53M
81.09%-437.87K
Net income continuous Operations
51.78%-1.04M
-653.71%-2.85M
80.08%-139.75K
132.77%501.88K
430.46%1.45M
62.65%-2.16M
145.14%514.56K
25.35%-701.69K
-11.01%-1.53M
81.09%-437.87K
Minority interest income
Net income attributable to the parent company
51.78%-1.04M
-653.71%-2.85M
80.08%-139.75K
132.77%501.88K
430.46%1.45M
62.65%-2.16M
145.14%514.56K
25.35%-701.69K
-11.01%-1.53M
81.09%-437.87K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
51.78%-1.04M
-653.71%-2.85M
80.08%-139.75K
132.77%501.88K
430.46%1.45M
62.65%-2.16M
145.14%514.56K
25.35%-701.69K
-11.01%-1.53M
81.09%-437.87K
Basic earnings per share
53.85%-0.12
-616.67%-0.31
77.78%-0.02
130.00%0.06
366.67%0.16
65.33%-0.26
140.00%0.06
25.00%-0.09
-11.11%-0.2
80.00%-0.06
Diluted earnings per share
53.85%-0.12
-616.67%-0.31
77.78%-0.02
130.00%0.06
366.67%0.16
65.33%-0.26
140.00%0.06
25.00%-0.09
-11.11%-0.2
80.00%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 4.34%27.64M-1.61%7.63M-8.41%5.51M17.76%6.44M11.16%8.07M51.64%26.49M52.10%7.75M11.40%6.01M54.92%5.47M110.58%7.26M
Operating revenue 4.34%27.64M-1.61%7.63M-8.41%5.51M17.76%6.44M11.16%8.07M51.64%26.49M52.10%7.75M11.40%6.01M54.92%5.47M110.58%7.26M
Cost of revenue -12.68%16.2M-4.14%4.72M-29.02%3.14M-14.51%3.63M-5.02%4.71M36.39%18.55M28.17%4.92M7.23%4.43M70.46%4.24M57.74%4.96M
Gross profit 44.13%11.45M2.77%2.91M49.23%2.36M129.01%2.82M46.12%3.35M105.23%7.94M125.14%2.83M25.00%1.58M17.88%1.23M663.15%2.3M
Operating expense 2.24%9.8M34.29%2.97M8.55%2.34M-14.09%2.25M-13.83%2.24M-0.38%9.58M-2.25%2.21M-11.93%2.16M11.44%2.62M1.51%2.6M
Selling and administrative expenses 18.85%6.75M58.84%2.21M20.14%1.65M-10.72%1.42M11.00%1.48M8.81%5.68M16.41%1.39M2.99%1.37M27.04%1.59M-7.85%1.33M
-Selling and marketing expense 2.52%3.55M29.32%1.08M8.91%919.29K-29.33%696.09K6.96%856.66K12.24%3.47M24.52%836.15K3.25%844.05K36.84%984.96K-8.93%800.92K
-General and administrative expense 44.40%3.2M103.34%1.13M38.08%729.42K19.74%720.42K17.09%622.84K3.85%2.22M6.01%554.71K2.59%528.27K13.72%601.63K-6.19%531.94K
Research and development costs -21.97%3.04M-7.39%758.86K-11.68%694.31K-19.28%831.86K-40.05%756.85K-11.29%3.9M-23.17%819.39K-29.71%786.14K-6.28%1.03M13.71%1.26M
Operating profit 200.56%1.65M-109.33%-57.96K103.49%20.08K141.08%569.56K472.48%1.12M71.47%-1.64M161.92%621.4K51.45%-574.89K-6.29%-1.39M86.70%-300.05K
Net non-operating interest income expense 31.84%-334.68K25.49%-74.49K25.83%-93.05K40.61%-76.68K33.72%-90.46K-29.55%-491.02K25.94%-99.97K-3.75%-125.46K-75.03%-129.12K-176.53%-136.48K
Non-operating interest income 104.25%158.71K-12.61%31.66K121.93%41.47K262.73%48.11K293.29%37.47K-19.54%77.7K107.77%36.23K-21.15%18.69K-10.41%13.26K-76.55%9.53K
Non-operating interest expense -16.54%439.04K-17.87%102.99K-21.30%104.94K-12.35%124.8K-13.73%117.12K16.13%526.06K-11.90%125.39K-1.91%133.34K60.75%142.39K50.87%135.76K
Total other finance cost 27.38%54.35K-70.79%3.16K173.74%29.58K----5.46%10.81K88.63%42.67K7.06%10.81K24.38%10.81K------10.25K
Other net income (expense) -15,123.75%-2.34M-325,247.00%-2.71M-62.32K174.91%10.9K421.72K-104.31%-15.39K-834-19,005.19%-14.56K
Special income (charges) -15,148.28%-2.35M-325,247.00%-2.71M---62.32K148.97%7.13K--421.72K-104.31%-15.39K---834--0-19,005.19%-14.56K--0
-Less:Impairment of capital assets --2.67M------------------------------------
-Less:Other special charges ---426.59K--0-----------426.59K--------------------
-Gain on sale of property,plant,equipment -590.99%-106.35K-5,450.84%-46.29K---62.32K148.97%7.13K---4.87K-90.04%-15.39K---834--0-19,005.19%-14.56K--0
Other non- operating income (expenses) --3.78K--0------3.78K------------------------
Income before tax 52.09%-1.03M-646.65%-2.85M80.68%-135.29K132.92%503.78K431.91%1.45M62.80%-2.15M145.73%520.59K25.48%-700.35K-11.04%-1.53M81.13%-436.53K
Income tax 15.06%11.57K-45.23%3.31K232.54%4.46K42.09%1.9K42.09%1.9K117.33%10.06K347.77%6.04K485.15%1.34K-12.13%1.34K-12.13%1.34K
Net income 51.78%-1.04M-653.71%-2.85M80.08%-139.75K132.77%501.88K430.46%1.45M62.65%-2.16M145.14%514.56K25.35%-701.69K-11.01%-1.53M81.09%-437.87K
Net income continuous Operations 51.78%-1.04M-653.71%-2.85M80.08%-139.75K132.77%501.88K430.46%1.45M62.65%-2.16M145.14%514.56K25.35%-701.69K-11.01%-1.53M81.09%-437.87K
Minority interest income
Net income attributable to the parent company 51.78%-1.04M-653.71%-2.85M80.08%-139.75K132.77%501.88K430.46%1.45M62.65%-2.16M145.14%514.56K25.35%-701.69K-11.01%-1.53M81.09%-437.87K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 51.78%-1.04M-653.71%-2.85M80.08%-139.75K132.77%501.88K430.46%1.45M62.65%-2.16M145.14%514.56K25.35%-701.69K-11.01%-1.53M81.09%-437.87K
Basic earnings per share 53.85%-0.12-616.67%-0.3177.78%-0.02130.00%0.06366.67%0.1665.33%-0.26140.00%0.0625.00%-0.09-11.11%-0.280.00%-0.06
Diluted earnings per share 53.85%-0.12-616.67%-0.3177.78%-0.02130.00%0.06366.67%0.1665.33%-0.26140.00%0.0625.00%-0.09-11.11%-0.280.00%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More